Health Law RX

JANUARY 30, 2024

By maintaining a robust compliance program, healthcare companies are better able to identify potential red flags early and to prevent violations of fraud and abuse laws. The DOJ Announcement stresses the importance of investing in strong compliance programs for both the buyers and sellers in business transactions.

Compliance 52

Compliance Due Diligence Fraud Governance 52

MedTrainer

AUGUST 2, 2023

Listen to a candid discussion on lessons learned from the 2023 federal investigation that uncovered fraudulent medical practice nationwide in this on-demand webinar: Moving Forward From the Nursing Fraud Scheme. However, it’s important to remember how critical this process is for mitigating risk, improving compliance, and earning trust.

Malpractice 52

Malpractice Due Diligence Compliance Licensing 52

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. There are considerable risks to adoption that may have deep compliance implications.

Pharmaceutical Industry 81

Pharmaceutical Industry Due Diligence Compliance Regulatory Compliance 81